How effective budget impact analysis drives reimbursement & coverage decisions, strengthening market access

Demonstrating the affordability of new therapies is crucial in securing reimbursement and market entry. But BIM expectations are changing. Learn exactly how to influence decisions with this practical guide to budget impact analysis in market access.

Why this guide is a must-have

• Explains how to strengthen your value story by applying pharmacoeconomics principles
• Provides working examples of how budget impact models (BIMs) are used by decision makers
• Gain best practice steps for developing structured, credible BIMs
• Learn how to avoid weak, unsubstantiated insights

Key failures that jeopardize cost-effectiveness analysis in healthcare

❌ Creating overcomplicated models that are difficult to validate, adapt, or explain to stakeholders

❌ Using a one-size-fits-all approach: failure to customize scenarios, cost perspectives and population inputs (causing misalignment with payer expectations)

❌ Lack of traceability, including poorly documented and inconsistent assumptions

❌ Inconsistencies & poor version control across multiple payer versions

What you’ll learn in this guide:

• How to implement the key principles of pharmacoeconomics:
  • designing a robust budget impact analysis framework
• Best practices for effective and credible BIMs
• Do’s and don’ts of creating a BIM:
  • what to include / leave out
  • when to make updates
• BIM expectations in the US vs. Europe
• The importance of adapting budget impact analysis to different payer perspectives and territories:
  • tailoring models to reflect regional policies, reimbursement structures, and decision criteria
• Demonstrating financial impact under different assumptions

Get the best practice insights you need to deliver cost–effectiveness analysis in healthcare that supports market access. Download the guide.